Assessing the feasibility of the GOTT (Gabapentinoid and Opioid Tapering Toolkit) in a primary care setting in North-East England.

Br J Pain · 2025 · PMC11559511 · PMID 39544411

Europe PMC DOI

hedged sentence

0.0118

closest p · 0.2× alpha

0.0118

boldest claim

The sentences

highly significantp = .0118actually significant

Whilst prescriptions of HDOs were falling before September 2019 with a slope of −0.0719 ± 0.0282, they continued to fall afterwards at a significantly steeper rate than before with a new slope of −0.195 ± 0.0350 and this change in trend was highly significant (ANCOVA, F (1,22) = 7.529, p = .0118) ( Figure 4 , Supplement Figure 2(i) ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.